
ProPhase Labs, Inc.: Clinically-proven remedies for colds and wellness, specializing in lozenges and nutrition products.
ProPhase Labs, Inc. was founded with a mission to create clinically-proven remedies that enhance health and wellness. Initially known for developing zinc gluconate glycine lozenges and homeopathic gum to alleviate common cold symptoms, the company has since expanded its focus. ProPhase now operates as a next-generation biotech, genomics, and diagnostics company, offering Whole Genome Sequencing solutions and developing innovative diagnostics and therapeutics, including early detection tests for esophageal cancer.
Notable figures affiliated with ProPhase Labs include its leadership team with extensive experience in biotech and healthcare innovation. The company has attracted significant investment from industry leaders who share its vision of revolutionizing healthcare. Key achievements include the development of industry-leading genomic solutions and potentially life-saving cancer diagnostics. ProPhase Labs has made a substantial impact by advancing early detection methods and contributing to the broader field of personalized medicine.
ProPhase Labs' most recent funding round was for $7M (USD) in January 2014.
As of Jan 1, 2014, ProPhase Labs has disclosed funding of $7M (USD).

Phase Genomics
phasegenomics.com

OPKO Health
opko.com

Phigenix
phigenix.com

Myriad Genetics
myriad.com

Guardant Health
guardanthealth.com

Personalis
personalis.com

Armata Pharmaceuticals
armatapharma.com

Lucid Diagnostics
luciddx.com

PhagePro
phageproinc.com

Quest Diagnostics

Oral Genome
oralgenome.com

Veru
verupharma.com

QHSLab
usaqcorp.com

Processa Pharmaceuticals

Prolocor
prolocor.com

EcoGenome
ecogenomellc.com

Phenomune
phenomune.com

Kyntra Bio
fibrogen.com

Precipio
precipiodx.com

Precision Theranostics